Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 358 of 6351
-
New Light-Based combo tackles tough lung cancers
Disease control Not yet recruitingThis phase II trial tests how well photoimmunotherapy (PIT) with ASP-1929 in combination with cemiplimab works in treating patients with stage IIIB-IV non-small cell lung cancer (NSCLC) that has not responded to previous treatment (refractory), that is not suitable for surgery (i…
Phase 2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Half-Dose malaria vaccine could double protection for millions
Vaccine Not yet recruitingThis is a single blind randomised controlled trial (Phase 3 trial). This study aims to assess whether a half-dose of the R21/Matrix-M malaria vaccine is as effective as the full dose in children and adults. The results will help optimize vaccine usage and improve malaria preventi…
Phase 4 • Sponsor: University of Oxford • Aim: Vaccine
Last updated Aug 06, 2026 00:00 UTC
-
New drug duo takes on rare, deadly lymphoma
Disease control Recruiting nowThis phase II trial tests how well nemtabrutinib in combination with pembrolizumab works in treating patients with Richter transformation, diffuse large B-cell lymphoma subtype (RT-DLBCL). Nemtabrutinib is in a class of medications called kinase inhibitors. It blocks a protein ca…
Phase 2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Magic mushroom therapy targets heavy drinking in new trial
Disease control Not yet recruitingThis study aims to determine the safety and preliminary efficacy of psilocybin-assisted psychotherapy in improving alcohol-related outcomes among adults with severe alcohol use disorder in a a double-blind, dose-comparison concurrent control, randomized trial. Participants will u…
Phase 2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New cocktail aims to make inoperable liver metastases removable
Disease control Not yet recruitingThis is a single-arm clinical study aiming to enroll 30 colon cancer patients with liver-only metastases. All eligible participants will undergo screening and enrollment after signing the informed consent form. All patients will receive stereotactic body radiation therapy (SBRT)…
Phase 2 • Sponsor: Fujian Medical University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Nasal spray vaccine aims to stop COVID-19 at the source
Vaccine Not yet recruitingThis phase 1 clinical trial will evaluate the safety, reactogenicity, and immunogenicity of RVX-sCPD9, given Intranasally (IN), as a booster dose to previously vaccinated healthy adults. The study is designed as a non-randomized, open-label, dose-escalation clinical trial evaluat…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Sep 06, 2026 00:00 UTC
-
Bright light, better mood? glasses that mimic morning sun tested for depression on dialysis
Symptom relief Not yet recruitingHemodialysis is an intensive treatment, with a lifestyle dictated by the organization of the dialysis center. This treatment is associated with a decrease in quality of life, an increase in sleep disorders, and depressive disorders. Light therapy could be a non-pharmacological o…
Sponsor: Centre Hospitalier Annecy Genevois • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Teamwork in care: could shared Self-Care lessons ease the toll of breast cancer treatment?
Symptom relief Not yet recruitingThis randomized controlled trial aims to evaluate the effect of dyadic self-care education provided to breast cancer patient-caregiver dyads receiving outpatient chemotherapy on patient self-care behaviors, anxiety levels, and caregiver anxiety levels and caregiver burden. Partic…
Sponsor: Ulviye Aydan NACAK • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Which kidney stone technique leaves no stone behind?
Disease control Not yet recruitingThe primary aim of the study is to compare stone free rates following ureteroscopic (URS) lithotripsy for renal stones with Thulium Fiber Laser (TFL) using a sheathless approach (low power laser settings) or using a flexible and navigable ureteral access sheath (FANS) with either…
Sponsor: Haukeland University Hospital • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a single dose of zoledronic acid safely treat bone loss in dialysis patients?
Disease control Not yet recruitingOsteoporosis is a frequent complication of chronic kidney disease (CKD) on dialysis, with an estimated prevalence of approximately 40%. It is associated with increased fracture risk, reduced quality of life, and higher mortality. Despite available therapies, management often rema…
Phase 1 • Sponsor: University of Campinas, Brazil • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can antioxidant pills boost skin and blood carotenoids to improve cardiometabolic health?
Disease control Not yet recruitingThis study aims to evaluate the effects of antioxidant-rich supplementation on skin carotenoid status, antioxidant status, and cardiometabolic health in overweight and obese individuals. The study may provide additional scientific evidence to support the further refinement of cur…
Sponsor: National University of Singapore • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can a Cancer-Fighting virus shrink resistant tumors?
Disease control Not yet recruitingThe goal of this clinical trial is to learn about the safety and tolerability of GO321 recombinant oncolytic virus injection, and if GO321 recombinant oncolytic virus injection works to treat advanced solid tumors in adults whose cancers have progressed after standard-of-care the…
Phase 1 • Sponsor: GeneSail Biotech (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can a single injection tame stubborn multiple sclerosis?
Disease control Not yet recruitingThis is a single-arm, open-label, dose-escalation clinical trial intended to evaluate the safety, efficacy and cellular pharmacokinetics of GT802 for the treatment of relapsing/refractory multiple sclerosis.
Early phase 1 • Sponsor: Daishi Tian • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Brain scans to reveal if new MS drug quietly calms inflammation
Disease control Recruiting nowREDEFINE-MS is a research study for people with relapsing multiple sclerosis (MS) who are participating in the RESHAPE-MS trial. The study aims to better understand how remibrutinib affects inflammation in the brain and spinal cord by using PET imaging, MRI scans, blood samples, …
Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can slow breathing soothe a failing heart?
Symptom relief Not yet recruitingBackground: Heart failure (HF) is a major global public health concern characterized by impaired cardiac function, high mortality, frequent hospital readmissions, and substantial healthcare burden. Autonomic nervous system (ANS) dysfunction plays a critical role in the pathophys…
Sponsor: Chung Shan Medical University • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Ablation without X-Rays: a new way to fix irregular heartbeats?
Disease control Not yet recruitingThis prospective, randomized, multicenter, open-label, non-inferiority interventional study aims to compare the therapeutic efficacy of percutaneous pulsed field ablation (PFA) guided by ultrasound alone versus fluoroscopy in patients with paroxysmal atrial fibrillation (AF). The…
Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a genetic test on the uterine lining solve the mystery of repeated IVF failure?
Knowledge-focused Not yet recruitingThis study aims to evaluate the clinical efficacy of transcriptome-based endometrial receptivity analysis (tb-ERA) and investigate the molecular mechanisms of abnormal receptivity in young women with unexplained recurrent implantation failure (RIF).
Sponsor: ShangHai Ji Ai Genetics & IVF Institute • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Ancient herbal remedy put to the test against Diabetes' nerve damage
Disease control Not yet recruitingDiabetic peripheral neuropathy (DPN) is a common complication of type 2 diabetes mellitus, affecting 35%-50% of diabetic patients. Its pathogenesis involves metabolic disorders induced by hyperglycemia and dyslipidemia, leading to irreversible damage to neurons and vascular endot…
Sponsor: The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Can a slight dose change boost IVF embryo success?
Disease control Not yet recruitingThis randomized controlled trial will compare two starting doses of follicle-stimulating hormone (FSH), 225 IU and 300 IU, during progestin-primed ovarian stimulation (PPOS) in women undergoing in vitro fertilization (IVF) who have a good reproductive prognosis. Participants will…
Sponsor: Vietnam Military Medical University • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
AI tailors brain workouts: a new hope for cognitive decline?
Disease control OngoingThis retrospective study aimed to validate and compare two individualized, closed-loop, AI-driven computerized cognitive training programs with a conventional non-AI training program in a real-world clinical setting. Using objective tablet-recorded data from patients' prior treat…
Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC